-
DAWN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Day One Biopharmaceuticals (DAWN)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 124.97 mm | 124.97 mm | 124.97 mm | 124.97 mm | 124.97 mm | 124.97 mm |
Cash burn (monthly) | 99.27 mm | 8.82 mm | 21.78 mm | 18.11 mm | 10.00 mm | 6.51 mm |
Cash used (since last report) | 206.56 mm | 18.35 mm | 45.32 mm | 37.68 mm | 20.81 mm | 13.55 mm |
Cash remaining | -81.59 mm | 106.62 mm | 79.65 mm | 87.29 mm | 104.15 mm | 111.42 mm |
Runway (months of cash) | -0.8 | 12.1 | 3.7 | 4.8 | 10.4 | 17.1 |
13F holders | Current |
---|---|
Total holders | 167 |
Opened positions | 34 |
Closed positions | 34 |
Increased positions | 60 |
Reduced positions | 39 |
13F shares | Current |
---|---|
Total value | 1.15 tn |
Total shares | 114.02 mm |
Total puts | 253.20 k |
Total calls | 134.70 k |
Total put/call ratio | 1.9 |
Largest owners | Shares | Value |
---|---|---|
AI Day 1 | 12.93 mm | $183.21 mm |
FMR | 12.89 mm | $163.28 bn |
Atlas Venture Life Science Advisors | 6.43 mm | $81.47 bn |
BlackRock | 6.16 mm | $77.99 bn |
Vanguard | 5.85 mm | $74.11 bn |
Ra Capital Management | 5.76 mm | $72.92 bn |
Braidwell | 4.87 mm | $61.75 bn |
Atlas Venture Fund XI | 4.87 mm | $70.46 mm |
BEN Franklin Resources | 3.88 mm | $49.20 bn |
Estuary Capital Management | 3.72 mm | $47.09 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Feb 25 | Jeremy Bender | Common Stock | Sell | Dispose S | No | No | 11.963 | 12,048 | 144.13 k | 128,015 |
18 Feb 25 | Dubow Adam | Common Stock | Sell | Dispose S | No | No | 11.963 | 4,646 | 55.58 k | 39,602 |
18 Feb 25 | Charles N York II | Common Stock | Sell | Dispose S | No | No | 11.963 | 4,370 | 52.28 k | 252,638 |
15 Feb 25 | Jeremy Bender | Common Stock | Option exercise | Acquire M | No | No | 0 | 11,687 | 0.00 | 140,063 |
15 Feb 25 | Jeremy Bender | Common Stock | Option exercise | Acquire M | No | No | 0 | 11,687 | 0.00 | 128,376 |
15 Feb 25 | Jeremy Bender | Common Stock | Option exercise | Acquire M | No | No | 0 | 4,750 | 0.00 | 116,689 |
15 Feb 25 | Jeremy Bender | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,562 | 0.00 | 111,939 |
15 Feb 25 | Jeremy Bender | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 11,687 | 0.00 | 175,313 |
15 Feb 25 | Jeremy Bender | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 11,687 | 0.00 | 128,565 |
15 Feb 25 | Jeremy Bender | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 4,750 | 0.00 | 33,250 |